Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 7/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29525350 | 0.82 | LMNA (0.68) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL3908136 | 0.82 | LMNA (0.68) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL28213156 | 0.81 | LMNA (0.58) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL1491974 | 0.76 | HPGD (0.62) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL27757206 | 0.76 | ESR1 (0.55) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL23795259 | 0.75 | HPGD (0.60) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL9561863 | 0.75 | LMNA (0.59) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL285141 | 0.75 | LMNA (0.64) | LMNATSHRHPGDHSD17B10ALOX15 | |
| SCHEMBL1742375 | 0.75 | LMNA (0.52) | LMNATSHRHSD17B10TDP1ALDH1A1 | |
| SCHEMBL10780992 | 0.75 | HPGD (0.59) | LMNATSHRHPGDHSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3266450-A1 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | Abraxis BioScience, LLC (US) | 2018-01-10 | — | — | EP | disclosed |
| CN-101579335-B | The preparation of medicament and methods for making and using same thereof | 阿布拉科斯生物科学有限公司 | 2016-08-03 | — | — | CN | disclosed |
| US-20160151325-A1 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | ABRAXIS BIOSCIENCE LLC (US) | 2016-06-02 | — | — | US | disclosed |
| US-20150111960-A1 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | ABRAXIS BIOSCIENCE LLC (US) | 2015-04-23 | — | — | US | disclosed |
| US-20150104521-A1 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | ABRAXIS BIOSCIENCE, LLC (US) | 2015-04-16 | — | — | US | disclosed |
| US-8853260-B2 | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof | ABRAXIS BIOSCIENCE, LLC (US) | 2014-10-07 | — | — | US | disclosed |
| EP-1023050-B1 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | ABRAXIS BIOSCIENCE LLC (US) | 2013-09-25 | — | — | EP | disclosed |
| US-20120231082-A1 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | DESAI NEIL P (US) | 2012-09-13 | — | — | US | disclosed |
| US-8137684-B2 | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof | ABRAXIS BIOSCIENCE, LLC (US) | 2012-03-20 | — | — | US | disclosed |
| EP-2272504-A2 | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof | Abraxis BioScience, LLC (US) | 2011-01-12 | — | — | EP | disclosed |
| US-20070116761-A1 | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof | ABRAXIS BIOSCIENCE, INC. | 2007-05-24 | — | — | US | disclosed |
| US-20070092563-A1 | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof | ABRAXIS BIOSCIENCE, INC. (US) | 2007-04-26 | — | — | US | disclosed |
| US-20070093547-A1 | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof | ABRAXIS BIOSCIENCE, LLC | 2007-04-26 | — | — | US | disclosed |
| US-20070087022-A1 | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof | ABRAXIS BIOSCIENCE, INC. (US) | 2007-04-19 | — | — | US | disclosed |
| EP-1023050-A4 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | AMERICAN BIOSCIENCE INC (US) | 2006-08-30 | — | — | EP | disclosed |
| CN-1515246-A | New preparation of medicine, its preparation and application method | �Ϻ���ͨ��ѧ | 2004-07-28 | — | — | CN | disclosed |
| CN-1267214-A | Novel preparation of medicament and preparation and application method thereof | VIVORX PHARMACEUTICALS INC (US) | 2000-09-20 | — | — | CN | disclosed |
| EP-1023050-A1 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | Vivorx Pharmaceuticals, Inc. (US) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999000113-A9 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | VIVORX PHARMACEUTICALS INC (US) | 1999-04-08 | — | — | WO | disclosed |
| WO-1999000113-A1 | NOVEL FORMULATIONS OF PHARMACOLOGICAL AGENTS, METHODS FOR THE PREPARATION THEREOF AND METHODS FOR THE USE THEREOF | VIVORX PHARMACEUTICALS, INC. (US) | 1999-01-07 | — | — | WO | disclosed |